U.S. Global Investors Holmes MacroTrends (MEGAX)

21.16
Net Asset Value
-0.52%
1 Day
+4.49%
Year-to-Date
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
1.94%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in a diversified portfolio of equity and equity-related securities. The equity and equity-related securities in which the fund primarily invests are common stocks, preferred stocks, convertible securities, rights and warrants, and depository receipts (ADRs and GDRs). The fund may invest up to 25% of its total assets in foreign securities that are not publicly traded in the U.S. It may also invest in sponsored or unsponsored American Depository Receipts (ADRs), which represent shares of foreign issuers; however, the ADRs are not included in the 25% limit on foreign issuers.

Performance

1 month+1.49% 3 years+11.01%
3 months+1.83% 5 years+10.49%
1 year+0.65% Since inception+8.35%
Data through --

Peer Comparisonvs. Mid-cap growth

 MEGAXCategory
Performance 5-yr return+10.49%+14.47%
Expense ratio1.94%1.33%
Risk 5 year sharpe ratio0.610.89
Net assets$45.5M$1.3B
Average market cap$17.7B$9.7B
Average P/E21.225.2
Portfolio turnover183%183%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyU.S. Global Investors
Fund manager & tenureFrank Holmes / 20 Years
Minimal initial investment$5,000.00
Minimum IRA investment$5,000.00

Holdings

U.S. stock81.53%
International stock7.37%
Cash5.70%
Fixed income5.40%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AAPL Apple5.36%
FB Facebook3.37%
ODFL Old Dominion Freight Line Inc3.02%
SWKS Skyworks Solutions Inc2.83%
ACT Actavis2.78%
SM SM Energy Co2.50%
GILD Gilead Sciences2.44%
MYL Mylan NV2.43%
ALXN Alexion Pharmaceuticals Inc2.40%
CAVM Cavium Inc2.27%

To view my watchlist

Not a member yet?

Sign up now for a free account